Shanghai Cell Therapy Group launches collaboration with USC researcher to improve the ex vivo expansion of hematopoietic stem cells for clinical applications
Shanghai Cell Therapy Group (SHCell) recently entered into a six-year research collaborative project with Professor Qi-Long Ying from the University of Southern California (USC). Through the project, sponsored by $3.6 million from …